Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries
Authors:
- Lars EdvinssonLELars Edvinsson
- Anette SamsASAnette Sams
- Inger Jansen-OlesenIJInger Jansen-Olesen
- Janos TajtiJTJanos Tajti
- Stefanie A KaneSKStefanie A Kane
- Ruth Z RutledgeRRRuth Z Rutledge
- Kenneth S KoblanKKKenneth S Koblan
- Raymond G HillRHRaymond G Hill
- Jenny LongmoreJLJenny Longmore
- 1 March 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 415 (1) , 39-44
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistBritish Journal of Pharmacology, 2000
- Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotilityPeptides, 1998
- Neuropeptides in headacheEuropean Journal of Neurology, 1998
- Quinine analogs as non-peptide calcitonin gene-related peptide (CGRP) receptor antagonistsBioorganic & Medicinal Chemistry Letters, 1997
- Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteriesNeuroscience Letters, 1997
- A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 ReceptorJournal of Biological Chemistry, 1996
- Inhibition of calcitonin gene-related peptide by h-CGRP(8–37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the catNeuroscience Letters, 1993
- Calcitonin Gene-Related Peptide and Cerebral Blood Vessels: Distribution and Vasomotor EffectsJournal of Cerebral Blood Flow & Metabolism, 1987
- Functional role of perivascular peptides in the control of cerebral circulationTrends in Neurosciences, 1985
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973